| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |